Missense variants in NOX1 and p22phox in a case of very-early-onset inflammatory bowel disease are functionally linked to NOD2.

Simone Lipinski, Britt-Sabina Petersen, Matthias Barann, Agnes Piecyk, Florian Tran, Gabriele Mayr, Marlene Jentzsch, Konrad Aden, Stephanie T Stengel, Ulrich C Klostermeier, Vrunda Sheth, David Ellinghaus, Tobias Rausch, Jan O Korbel, Michael Nothnagel, Michael Krawczak, Christian Gilissen, Joris A Veltman, Michael Forster, Peter Forster, Clarence C Lee, Annette Fritscher-Ravens, Stefan Schreiber, Andre Franke, Philip Rosenstiel
Year of publication:
Journal title abbreviated:
Cold Spring Harb Mol Case Stud
Journal title long:
Cold Spring Harbor molecular case studies
Whole-genome and whole-exome sequencing of individual patients allow the study of rare and potentially causative genetic variation. In this study, we sequenced DNA of a trio comprising a boy with very-early-onset inflammatory bowel disease (veoIBD) and his unaffected parents. We identified a rare, X-linked missense variant in the NAPDH oxidase NOX1 gene (c.C721T, p.R241C) in heterozygous state in the mother and in hemizygous state in the patient. We discovered that, in addition, the patient was homozygous for a common missense variant in the CYBA gene (c.T214C, p.Y72H). CYBA encodes the p22phox protein, a cofactor for NOX1. Functional assays revealed reduced cellular ROS generation and antibacterial capacity of NOX1 and p22phox variants in intestinal epithelial cells. Moreover, the identified NADPH oxidase complex variants affected NOD2-mediated immune responses, and p22phox was identified as a novel NOD2 interactor. In conclusion, we detected missense variants in a veoIBD patient that disrupt the host response to bacterial challenges and reduce protective innate immune signaling via NOD2. We assume that the patient's individual genetic makeup favored disturbed intestinal mucosal barrier function.